MARKET

BBCMF

BBCMF

LIR Life Sciences
OTCPK
0.200
+0.150
+300.00%
Closed 09:36 07/24 EDT
OPEN
0.200
PREV CLOSE
0.050
HIGH
0.200
LOW
0.200
VOLUME
769
TURNOVER
154
52 WEEK HIGH
1.750
52 WEEK LOW
0.050
MARKET CAP
5.73M
P/E (TTM)
-0.1890
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BBCMF last week (0713-0717)?
Weekly Report · 5d ago
LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Barchart · 07/16 17:00
Weekly Report: what happened at BBCMF last week (0706-0710)?
Weekly Report · 07/13 09:32
Weekly Report: what happened at BBCMF last week (0629-0703)?
Weekly Report · 07/06 09:34
Weekly Report: what happened at BBCMF last week (0622-0626)?
Weekly Report · 06/29 09:32
Weekly Report: what happened at BBCMF last week (0615-0619)?
Weekly Report · 06/22 09:36
LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Barchart · 06/17 17:00
Weekly Report: what happened at BBCMF last week (0608-0612)?
Weekly Report · 06/15 09:36
More
About BBCMF
LIR Life Sciences Corp. is a Canada-based company. The Company is engaged in developing therapies across multiple treatment areas, with a focus on obesity and metabolic disorders. It develops glucagon-like peptide-1 (GLP-1) based therapies for patients. It has access to a drug delivery system and plans to utilize technology to enable the needle-free administration of complex large-molecule biologics which provides a potential alternative to injectable treatments across a wide variety of treatments and diseases. The Company develops LIR001 Dual-Action Therapy (LIR001). LIR001 combines GLP-1 receptor agonists with other drugs to enhance obesity treatment by targeting both metabolic and behavioral factors. GLP-1 receptor agonists, such as liraglutide and semaglutide, regulate blood sugar, promote insulin release, and slow gastric emptying, leading to reduced appetite and improved insulin sensitivity.

Webull offers LIR Life Sciences Corp stock information, including OTCPK: BBCMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBCMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BBCMF stock methods without spending real money on the virtual paper trading platform.